Home Cart Sign in  
Chemical Structure| 880549-30-4 Chemical Structure| 880549-30-4

Structure of AMD-070 HCl
CAS No.: 880549-30-4

Chemical Structure| 880549-30-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AMD-070 HCl is a potent and selective antagonist of CXCR4 with an IC50 value of 13 nM in a CXCR4 125I-SDF inhibition binding assay and inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AMD-070 HCl

CAS No. :880549-30-4
Formula : C21H28ClN5
M.W : 385.93
SMILES Code : NCCCCN(CC1=NC2=CC=CC=C2N1)[C@H]3CCCC4=C3N=CC=C4.[H]Cl
MDL No. :MFCD23160058
InChI Key :DBNMEMJSDAAGNZ-FYZYNONXSA-N
Pubchem ID :71576687

Safety of AMD-070 HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of AMD-070 HCl

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U2932 cells 1–90 µM 72 h Assessed cell growth and apoptotic effects, showing that U2932 cells were unresponsive to AMD070 and WK1 treatment Int J Mol Sci. 2019 Sep 24;20(19):4740
RI-1 cells 1–90 µM 72 h Assessed cell growth and apoptotic effects, showing that RI-1 cells were unresponsive to AMD070 and WK1 treatment Int J Mol Sci. 2019 Sep 24;20(19):4740
SuDHL4 cells 1–90 µM 72 h Assessed cell growth and apoptotic effects, showing that AMD070 and WK1 exhibited pro-apoptotic effects in SuDHL4 cells Int J Mol Sci. 2019 Sep 24;20(19):4740
BL2 cells 1–90 µM 72 h Assessed cell growth and apoptotic effects, showing that AMD070 and WK1 exhibited pro-apoptotic effects in BL2 cells Int J Mol Sci. 2019 Sep 24;20(19):4740
pancreatic cancer cells (MIA PaCa-2) 2.5 µM 72 h To evaluate the effect of AMD070 on the colonization of radiation-resistant pancreatic cancer cells. Results showed that AMD070 significantly suppressed the colonization of radiation-resistant cells. Oncol Rep. 2022 Apr;47(4):68
radiation-resistant pancreatic cancer cells (MIA PaCa-2 and SW1990) 1 µM 24 h To evaluate the inhibitory effect of AMD070 on the invasion ability of pancreatic cancer cells enhanced by CXCL12 treatment or coculture with fibroblasts. Results showed that AMD070 significantly suppressed the invasion ability of radiation-resistant pancreatic cancer cells. Oncol Rep. 2022 Apr;47(4):68

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Bleomycin-induced pulmonary fibrosis model Oral gavage 400μg/mouse Daily for 21 consecutive days To evaluate the efficacy of AMD070 in a BLM-induced pulmonary fibrosis model. Results showed AMD070 significantly improved survival but had no significant effect on lung fibrosis. PLoS One. 2016 Mar 21;11(3):e0151765

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.59mL

0.52mL

0.26mL

12.96mL

2.59mL

1.30mL

25.91mL

5.18mL

2.59mL

References

 

Historical Records

Categories